Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #347628 on Innovation Pharmaceuticals Inc (IPIX)
Longpicker
02/20/21 2:35 AM
#347631 RE: DrBones #347628
CallMeCrazy
02/20/21 4:06 AM
#347637 RE: DrBones #347628
... extensive preclinical research on Kevetrin shows the re-activation of p53 across a wide spectrum of cancer lines including colon, lung, breast and pancreatic cancers. The market potential for Kevetrin in treating drug-resistant cancers is worth $5 billion a year. Other cancers could easily represent an additional $5 billion annually,... emohasis added